Prostate Health Market Expected to Reach US ~$68.0 Billion and CAGR 9.1% by 2030 – Polaris Market Research
The global Prostate Health Market size is expected to reach USD 68.0 billion by 2030 according to a new study by Polaris Market Research.
The market’s growth is driven by increasing investments and grants from government organizations in cancer. Various groups are raising cancer awareness and encouraging innovative cancer treatments. This is enhanced by offering funds to researchers to further their research.
Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/prostate-health-market/request-for-sample
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
The various cancer organizations actively supporting cancer through grants include Prostate Cancer Foundation, Cancer Research Institute, Zero organizations, the American Cancer Society, etc. There is an extensive network of cancer organizations in North America and Europe. The Cancer Research Institute has granted 100 research grants to studies and initiatives related to cancer. The organization is investing heavily in new immunotherapy health treatments for cancer. The financial support totals around $26 Billion, with $9 Billion of the CRI Prostate Cancer Initiative funds.
Based on the treatment, the radiation therapy segment accounted for the leading share in the market in 2021. Radiation therapy kills cancer cells by utilizing high-powered light. External beam radiation therapy is a treatment option for cancer. It can also be administered after surgery to eliminate any remaining cancer cells if there is a chance that the tumor will spread or return.
Radiation treatment can help slow down the growth of cancer and ease pain such as discomfort if it has migrated to other parts of the body, such as the bones. Thus, the benefits of radiation therapy for cancer are boosting segmental growth.
Buy a Premium Report – https://www.polarismarketresearch.com/checkouts/12851
Market players include Abbott Laboratories, Amgen Inc., Astellas Pharma Inc., Pfizer Inc., AstraZeneca PLC, Merck & Co., Inc., Bayer AG, Eli Lilly and Company, Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Ferring Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Johnson & Johnson, and Siemens Healthcare AG.are some key players operating in the global market.
Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/prostate-health-market/inquire-before-buying
(You may enquire about a reported quote OR available discount offers to our sales team before purchase.)
Polaris Market Research has segmented the prostate health market report based on disease indication, modality, treatment, and region:
Prostate Health, Disease Indication Outlook (Revenue – USD Billion, 2018 – 2030)
- Prostate Cancer
- AR Directed Therapies
- Hormone ADT
- Cytotoxic Agents
- PARP Inhibitors
- Benign Prostate Hyperplasia (BPH)
- Other Alpha Blockers
- 5 Alpha Reductase
- Over the counter
Prostate Health, Modality Outlook (Revenue – USD Billion, 2018 – 2030)
Prostate Health, Treatment Outlook (Revenue – USD Billion, 2018 – 2030)
- Radiation Therapy
- Hormone Therapy
Browse detailed report with in-depth TOC – Prostate Health Market
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.
Polaris Market Research